Loading insider details...
Beta
Latest Form 4 (Mar 25, 2026): Grant/Award of 45,867 PYXS shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Mar 25, 2026 | Pyxis Oncology, Inc. (PYXS) | Grant/Award | 45,867 | n/a |
| Aug 26, 2025 | CDT Equity Inc. (CDT) | Grant/Award | 35,000 | n/a |
| Apr 2, 2025 | Pyxis Oncology, Inc. (PYXS) | Grant/Award | 36,979 | $36.2K |
| Apr 2, 2025 | CONDUIT PHARMACEUTICALS INC. (CDT) | Grant/Award | 47,612 | $42.4K |
| Dec 20, 2024 | CONDUIT PHARMACEUTICALS INC. (CDT) | Grant/Award | 420,000 | $29.8K |
| Nov 20, 2024 | CONDUIT PHARMACEUTICALS INC. (CDT) | Grant/Award | 437,976 | $40.2K |
| May 17, 2024 | SpringWorks Therapeutics, Inc. (SWTX) | Grant/Award | 4,095 | n/a |
| Apr 24, 2024 | CONDUIT PHARMACEUTICALS INC. (CDT) | Grant/Award | 400,664 | n/a |
| Mar 28, 2024 | Pyxis Oncology, Inc. (PYXS) | Grant/Award | 35,219 | n/a |
| Dec 14, 2023 | CONDUIT PHARMACEUTICALS INC. (CDT) | Grant/Award | 65,000 | $358.1K |